Samsung's blood pressure monitoring app earns medical device approval in S. Korea
SEOUL, April 21 (Yonhap) -- Samsung Electronics Co. said Tuesday its blood pressure monitoring mobile application has earned medical device approval in South Korea.
The Ministry of Food and Drug Safety has granted the Software as a Medical Device (SaMD) license to its health monitoring app, according to Samsung.
The software leverages a smartwatch's sensors and can regularly check a person's blood pressure.
Samsung said it plans to release the app no later than the third quarter of the year. It will run on wearable devices that have blood pressure checking sensors, such as its Galaxy Watch Active2.
South Korea's drug safety ministry in February revised its instructions on medical-purpose mobile applications to foster the country's ICT industry. So far, 35 mobile apps have earned SaMD approval from the ministry.
kdon@yna.co.kr
(END)
-
(Yonhap Interview) Fintech startup AIM aims to bring professional wealth services to ordinary investors
-
N.K. leader declares victory in fight against COVID-19: state media
-
N. Korea appears to release border dam water without prior notice: official
-
7 dead, 6 missing in heaviest rainfall in 80 years
-
(2nd LD) 7 dead, 6 missing in heaviest rainfall in 80 years
-
(Yonhap Interview) Fintech startup AIM aims to bring professional wealth services to ordinary investors
-
7 dead, 6 missing in heaviest rainfall in 80 years
-
(5th LD) 8 dead, 7 missing in record rainfall in Seoul, surrounding areas
-
N. Korea appears to release border dam water without prior notice: official
-
(LEAD) 7 dead, 6 missing in heaviest rainfall in 80 years
-
(2nd LD) S. Korean F-4E fighter crashes into Yellow Sea, no causalities: Air Force
-
KBO pushing for holding season openers in U.S. in 2024: commissioner
-
(4th LD) Samsung heir Lee granted special presidential pardon
-
(LEAD) Another person who disappeared into manhole amid downpours found dead
-
(LEAD) S. Korean F-4E fighter crashes during operation over Yellow Sea: Air Force